Stay updated on LY2963016 vs Lantus in Chinese Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the LY2963016 vs Lantus in Chinese Type 2 Diabetes Clinical Trial page.

Latest updates to the LY2963016 vs Lantus in Chinese Type 2 Diabetes Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedRevision: v3.4.2 was added and v3.4.1 removed; the substantive study content and details appear unchanged.SummaryDifference0.0%

- Check17 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0, a minor version update in the study documents area. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check31 days agoChange DetectedUI and metadata updates were made to the study page, including showing the glossary and minor labeling/capitalization changes, and the revision version (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check38 days agoChange DetectedRevision update from v3.3.3 to v3.3.4 appears on the page; no substantive changes to study content or layout are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded a dedicated Locations section with multiple Chinese provinces and cities (Anhui, Gansu, Guangdong, Henan, Hubei, Hunan, Jiangsu, Jilin, Liaoning, Ningxia, Shandong, Shanxi, Sichuan) and Nanjing, and updated the page to revision v3.3.3; removed the older HHS Vulnerability Disclosure and prior location sections.SummaryDifference1%

- Check89 days agoChange DetectedRevision: v3.3.2 is now displayed, replacing the previous v3.3.1 revision. This appears to be a minor site update with no changes to study details or navigation.SummaryDifference0.0%

Stay in the know with updates to LY2963016 vs Lantus in Chinese Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY2963016 vs Lantus in Chinese Type 2 Diabetes Clinical Trial page.